NINDS Awards $150,000 Grant to NuvOx Pharma for Development of Field-ready Syringe for Oxygen Delivery Drug.

NuvOx Pharma, a clinical stage biotechnology company based in Tucson, Arizona, has received a Phase I SBIR grant for $150,000 from the National Institutes of Health, specifically the National Institute of Neurological Diseases and Stroke (NINDS). This grant will fund development of a novel syringe sonication device that may allow quick preparation of an investigational drug for oxygen delivery.

Read full article here